Capstan Medical today announced the first successful transcatheter mitral valve replacements using its novel implant and surgical robotics system. Santa Cruz, California–based Capstan Medical said it’s the first time a minimally invasive robotic structural heart platform has been used in clinical practice. “Today marks a pivotal moment in the evolution of structural heart therapy,” Capstan […]
Structural heart
Capstan Medical raises $110M in Series C round ahead of structural heart robot’s first-in-human procedure
Capstan Medical has raised $110 million in new funding from an oversubscribed Series C round, the structural heart surgical robot developer said today. The funding round was led by Eclipse, with participation from Yu Galaxy and Intuitive Ventures, all three of which had previously invested in Capstan. Joining them in the Series C round is […]
Studies support anti-stroke PFO closure devices from Abbott, Gore
A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired […]
St. Jude Medical launches pediatric trial for Amplatzer Duct Occluder II AS cardiac implant
St. Jude Medical (NYSE:STJ) said today that it’s launching a pediatric clinical trial of a version of its Amplatzer cardiac implant for treating a congenital heart defect. The 50-patient ADO II AS study is designed to enroll 2 patient cohorts: at least 15 patients weighing 4.4 lbs. (2kg) or less and at least 25 patients weighing more […]
